UK Industry ‘Struggling’ With Skill Gaps In AI, Robotics & Data Analytics

 
• By Ian Schofield
  
Generate a summary of this article
Listen to this article
Beta

A new report says that pharma firms are finding it difficult to recruit staff with experience in emerging scientific technologies, particularly in areas such as regulatory and quality assurance. COVID-19, Brexit and competition for talent with other countries and industry sectors are cited as key factors.

Drawing a bridge and conquering adversity business concept
The UK pharma industry wants to bridge the AI/digital skills gap • Source: Shutterstock

The pharmaceutical industry in the UK is increasingly adopting new digital tools such as artificial intelligence (AI) and big data analytics to support innovative drug discovery and development, but “many companies are struggling to find and attract workers with the necessary skills,” says a new report from the Association of the British Pharmaceutical Industry.

While good progress has been made in addressing previously identified skills gaps, particularly in areas such as formulation science and...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By Saba Afreen

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     
    • By Anabel Costa-Ferreira and Ian Schofield

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography